Advertisement

COVID-19: India to decide emergency use authorisation of Sputnik V vaccine today

Follow The Hawk on Google News+ Follow

Advertisement


New Delhi: Meeting of Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) will be held on Wednesday to deliberate on emergency use authorisation application of Russian vaccine Sputnik V.

The vaccine manufacturers in India, Dr Reddy's, have already submitted the safety and immunogenicity data of the third phase trials.

Advertisement

On Tuesday, Union Health Minister Harsh Vardhan had said seven more COVID-19 vaccine candidates are in stages of clinical trials. He made the statement after receiving the second dose of the COVID-19 vaccine at Delhi Heart and Lung Institute.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

Harsh Vardhan had said, "Around seven more COVID vaccine candidates are in clinical trials. Some of them are in the advanced phase of the trials. Around two dozen vaccines are in pre-clinical trials."

In September 2020, Dr Reddy's partnered with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V and for its distribution rights in India.

Advertisement

The vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia on August 11 last year.

India already has two approved COVID-19 vaccines -- Covaxin and Covishield -- that are currently being administered to the public. (ANI)

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST